Heron Therapeutics | HRTX - Umsatzerlöse

Aktienkurs
0.78
Täglich Wechseln
-0.04 -4.74%
Monatlich
-34.57%
Jährlich
-67.29%
Q1 Prognose
0.76




Der Umsatz Veränderung Datum
ALKERMES USD 384.5M 9.7M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Amarin USD 49.22M 451K 2025-12
ANI Pharmaceuticals USD 247.06M 19.25M 2025-12
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
Eisai JPY 219.94B 22.58B 2025-12
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Esperion Therapeutics USD 168.45M 81.14M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
Insmed USD 263.8M 121.8M 2025-12
Ligand Pharmaceuticals USD 59.66M 55.8M 2025-12
Merck USD 16.4B 880M 2025-12
Nektar Therapeutics USD 24.12M 635K 2024-09
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Pacira USD 196.87M 17.35M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Surmodics USD 29.92M 96.16M 2024-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
Veracyte USD 140.6M 8.7M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12